• EHEC Delays Danazol-Induced Precocious Puberty

  2026-10-06

  A 2025 rat study evaluated an Eclipta prostrata and Hordeum vulgare extract complex in two models of precocious puberty induced by Danazol or a high-fat diet. The extract complex delayed vaginal opening, reduced ovarian maturation, and attenuated hypothalamic GnRH mRNA elevation, providing preliminary evidence for central hypothalamic–pituitary–gonadal axis modulation rather than clinical proof of efficacy.

• Danazol: Interpreting Endocrine Model Evidence

  2026-10-05

  Danazol and Danocrine are often discussed as endocrine modulators, but their greatest research value may lie in how they expose the limits of HPG-axis models. This article examines steroidogenesis, LH regulation, the 2025 rat study, product provenance, and the boundaries between mechanistic evidence and translational claims.

• NLRP3-Driven Astrocyte Changes in Morphine Tolerance

  2026-10-05

  Yuan et al. link NLRP3 inflammasome activation with a shift toward an A1-like reactive astrocyte profile during morphine tolerance. Their combined behavioral, molecular, and imaging evidence supports a neuroinflammatory mechanism, while pharmacological inhibition identifies NLRP3 as a candidate pathway rather than a clinically validated target.

• Hoechst 33342: Principles, Evidence and Limits

  2026-10-03

  Hoechst 33342 is a bis-benzimidazole fluorescent dye used to visualize DNA-containing structures, but nuclear fluorescence alone cannot establish cell-cycle phase, apoptosis, or a signaling mechanism. This overview explains what the stain can show, how it relates to a 2025 hypoxia pulmonary hypertension study, and where interpretation requires caution.

• Cabazitaxel Workflow for Resistant Cancer Models

  2026-10-02

  Cabazitaxel (XRP6258, SKU B2157) provides a practical research compound for studying antiproliferative responses and microtubule dynamics disruption in taxane-resistant or P-glycoprotein-expressing cancer models. It is suitable for controlled DMSO- or ethanol-based workflows, but it is insoluble in water, prepared solutions should be used promptly, and the dossier does not establish clinical dosing or dose equivalence.

• Viral RIPK3 Degradation and Inflammation

  2026-10-01

  Liu et al. identified a class of orthopoxvirus proteins that recruits host ubiquitin machinery to degrade RIPK3, thereby suppressing necroptosis while reshaping viral inflammation and pathogenicity. The study combines a targeted siRNA screen, viral genetics, biochemical validation, and mouse infection models to establish the vIRD–RIPK3 axis as an evolutionary determinant of virus–host interaction.

• 3-Dehydroteasterone Derivatives: Assay-Dependent Activity

  2026-10-01

  Valdés and co-workers developed benzoate-substituted 3-dehydroteasterone analogs and evaluated them with rice lamina inclination and bean second-internode bioassays. The study shows that side-chain architecture, aromatic substitution, and the choice of plant assay strongly influence apparent brassinosteroid activity.

• MDL 28170: Calpain Signaling in Assay Design

  2026-09-30

  MDL 28170 is a cell-permeable calpain inhibitor that helps dissect protease-driven neuronal injury, synaptic dysfunction, and cell death. This article translates recent BDNF/TrkB findings into practical assay decisions while distinguishing calpain effects from cathepsin B activity and downstream apoptosis.

• NF 449: Precision in P2X1 Platelet Biology

  2026-09-30

  NF 449 connects exceptionally potent P2X1 blockade with a translational framework for dissecting ATP-driven platelet activation, interpreting selectivity, and advancing antithrombotic agent research without confusing mechanistic promise with clinical proof.

• RIPA Lysis Buffer (Strong) in Glioma Assays

  2026-09-29

  Translate glioma pathway discoveries into practical Western blot, immunoprecipitation, and phosphoprotein workflows with a detergent-rich lysis strategy. This guide shows where RIPA Lysis Buffer (Strong) excels, when its strength can compromise protein complexes, and how to optimize sample handling for CSRP2–PDGFRA/PI3K/AKT validation.

• Meropenem Workflows for Carbapenem Resistance

  2026-09-29

  Meropenem supports reproducible susceptibility testing, resistance-mechanism mapping, and Gram-negative infection model development. This workflow connects antibacterial phenotype data with plasmid transmission evidence while emphasizing compound handling, assay controls, and research-only interpretation.

• Diphenyleneiodonium Chloride in Redox Assays

  2026-09-28

  Diphenyleneiodonium chloride helps dissect NOX-linked redox changes while also enabling GPR3-related cAMP signaling experiments. This workflow-focused guide shows how to separate enzyme inhibition, receptor pharmacology, and time-dependent Nrf2 responses for more defensible oxidative stress research.

• APEX2 Supports TERT Expression in Human Stem Cells

  2026-09-28

  A 2024 preprint reports that APEX2, unlike its paralog APEX1, is needed for efficient TERT expression and telomerase activity in human embryonic stem cells, with related findings in a melanoma cell line. RNA-seq and chromatin immunoprecipitation point to repetitive DNA regions as candidate sites linking APEX2-dependent DNA repair with gene expression, although the mechanism remains to be tested.

• Brefeldin A (BFA): Practical Assay Design

  2026-09-27

  A scenario-based guide to using Brefeldin A (SKU B1400) in cell viability, trafficking, ER-stress, and apoptosis experiments. It distinguishes product-reported parameters from workflow recommendations and explains how to interpret results without over-attributing effects.

• Dye Models Improve Visibility of Small Biopsies

  2026-09-26

  Nonsiri and colleagues compared five dyes as visibility aids for very small tissue samples during routine pathology preparation. Their findings identify hematoxylin as a practical option: it improved sample observability while avoiding the diagnostic interference and toxicity concerns that favored it over merbromin and alcian blue.

8637 records 1/576 page Next 12345 下5页 Last page